Morgan Group Holding Co. (MGHL)
OTC PINK OTC PINK Primary 
Claritev Corporation (CTEV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Claritev Corporation (CTEV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Morgan Stanley Keeps Pushing
Morgan Stanley delivered a strong Q4 2025, beating top- and bottom-line estimates with 10.4% revenue growth and robust segment performance. MS achieved a 32% consolidated pre-tax margin and improved efficiency ratio to 68%, reflecting disciplined expense management and operational gains. Wealth Management and Institutional Securities segments posted double-digit revenue growth, fueled by elevated M&A, underwriting, and asset management activity.
Morgan Stanley Q4 Earnings Beat on IB Strength, Decent Trading Gains
MS posts 21% earnings jump in Q4 2025 as investment banking fees surge 47% on strong M&A and IPO activity.
Morgan Stanley posts Q4 earnings beat driven by wealth management, investment banking growth
Morgan Stanley (NYSE:MS) shares rose 4% after the firm delivered strong fourth quarter earnings that exceeded Wall Street expectations on both revenue and earnings per share (EPS). The bank posted net revenues of $17.89 billion, surpassing the consensus estimate of $17.66 billion, marking 10.3% year-over-year growth driven by strength in wealth management.
Morgan Stanley Q4 Review: Strong Fundamentals Priced In (Downgrade)
Morgan Stanley delivered strong Q4 results, with 10% revenue growth and 21.8% return on tangible common equity. MS's wealth management business drove record advisory revenue, robust inflows, and margin expansion, reinforcing its fee-based, recurring revenue model. The bank's capital position remains excellent, supporting ongoing buybacks and a secure 2.2% dividend yield.
Morgan Stanley tops estimates driven by wealth management
CNBC's Leslie Picker reports on the company's quarterly earnings results.
Morgan Stanley is about to report earnings. Here's what to expect
Stocks are trading at record highs, which could provide a boost to Morgan Stanley's massive wealth management business.
Ascentage Pharma Group International (AAPG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Ascentage Pharma Group International (AAPG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Xvivo Perfusion AB (publ) (XVIPY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Xvivo Perfusion AB (publ) (XVIPY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Zealand Pharma A/S (ZLDPF) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Zealand Pharma A/S (ZLDPF) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Medline Inc. (MDLN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Medline Inc. (MDLN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Omada Health, Inc. (OMDA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Omada Health, Inc. (OMDA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
